Wiregraph

Market coverage built from listed-company disclosures. Email [email protected] for any enquiries.

Copyright © 2025-2026 Wiregraph.com | Market data and charting by TradingView.com

BAVARIAN NORDIC

BAVA.CODK0015998017NASDAQ CopenhagenDKDKK
Stock price
BAVARIAN NORDIC
Loading chart...

Coverage

Latest articles

Nations stockpile mpox vaccine amid rising geopolitical fears
9 Jul 2025, 14:48BAVA.CONASDAQ Copenhagen

Filings

Recent filings

FilingDate
Bavarian Nordic A/S - Articles of Association8 Sept 2021
Bavarian Nordic Reports Positive Results from Human Challenge Trial of its RSV Vaccine Candidate1 Sept 2021
Bavarian Nordic Announces First Half 2021 Results 25 Aug 2021
Bavarian Nordic Initiates Phase 2 Clinical Trial of COVID-19 Booster Vaccine 23 Aug 2021
Bavarian Nordic Receives Funding from the Danish Ministry of Health to Advance the Development of COVID-19 Booster Vaccine23 Aug 2021
Bavarian Nordic Reports Initial Results from First-in-Human Trial of COVID-19 Vaccine 9 Aug 2021
Bavarian Nordic A/S - Articles of Association10 Jun 2021
Search

Danish vaccine maker Bavarian Nordic will supply an undisclosed European country with its smallpox and mpox vaccine under a new contract valued at over 200 million Danish Krone, the company announced Wednesday.

Bavarian Nordic sells vaccine voucher for $160 million
20 Jun 2025, 17:26BAVA.CONASDAQ Copenhagen

Danish vaccine company Bavarian Nordic has entered an agreement to sell a Priority Review Voucher for a total of $160 million, the company said Wednesday.

  • Previous
  • 1
  • 2
  • 3
  • Next
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
10 Jun 2021
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise10 Jun 2021
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program2 Jun 2021
Bavarian Nordic Announces Marketing and Distribution Agreement with Dynavax to Launch HEPLISAV B® Hepatitis B Vaccine in Germany27 May 2021
Bavarian Nordic Announces Interim Results for the First Three Months of 202127 May 2021
  • Previous
  • 1
  • More pages
  • 16
  • 17
  • 18
  • More pages
  • 78
  • Next
Company
BAVARIAN NORDIC
BAVA.CONASDAQ Copenhagen
Website: Unavailable
Coverage
14
Filings
927